UBS Group’s Inspire Veterinary Partners IVP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-310,982
Closed -$14.9K 10832
2025
Q4
$14.9K Buy
310,982
+310,406
+53,890% +$156K ﹤0.01% 7978
2025
Q3
$565 Sell
576
-11,574
-95% -$10.6K ﹤0.01% 9623
2025
Q2
$20.5K Buy
12,150
+200
+2% +$317 ﹤0.01% 8416
2025
Q1
$20.4K Buy
11,950
+11,378
+1,989% +$29.6K ﹤0.01% 8215
2024
Q4
$2.75K Buy
+572
New +$3.43K ﹤0.01% 8994
2024
Q3
Sell
-1,059
Closed -$41.8K 9786
2024
Q2
$41.8K Buy
+1,059
New +$85.8K ﹤0.01% 6831
2024
Q1
Hold
0
-$192 9678
2023
Q4
Sell
-1
Closed -$1.74K 8825
2023
Q3
$4.62K Buy
+1
New +$4.77K ﹤0.01% 7428

Other funds holding IVP

UBS Group's IVP Position: Q1 2026 in Review

UBS Group sold out of Inspire Veterinary Partners (IVP) in Q1 2026, closing a stake of 310,982 shares — an estimated $14.9K sold.

UBS Group first reported a position in IVP in Q3 2023 and held it in 7 quarters. The position peaked at $41.8K in Q2 2024. 2 funds tracked by Wall St. Rank hold IVP as of Q1 2026.

  • UBS Group reported no remaining Inspire Veterinary Partners position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 310,982 Inspire Veterinary Partners shares in Q1 2026, an estimated $14.9K.
  • UBS Group first reported a position in Inspire Veterinary Partners in Q3 2023 and held it in 7 quarters.
  • UBS Group's Inspire Veterinary Partners position peaked at $41.8K in Q2 2024.
  • 2 funds tracked by Wall St. Rank held Inspire Veterinary Partners as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.